Financhill
Back

Protara Therapeutics Stock Predictions

Protara Therapeutics Stock Forecast

  • Over the next 52 weeks, Protara Therapeutics has on average historically risen by 0.6% based on the past 10 years of stock performance.
  • Protara Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Protara Therapeutics Stock Undervalued?
    The current Protara Therapeutics [TARA] share price is $5.37. The Score for TARA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • TARA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Protara Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Protara Therapeutics has on average historically risen by 0.6% based on the past 10 years of stock performance.

Protara Therapeutics Stock Rating

Buy
55
Protara Therapeutics (TARA) is a Buy

Is Protara Therapeutics overpriced?

  • Protara Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Protara Therapeutics Stock Price History

Is TARA stock going to rise?

  • The current trend is moderately bullish and TARA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protaratx.com

52-Week Data

52-Week High:
10.48
52-Week Low:
1.60

Prediction Charts

Market Cap:
110.8M
Price in USD:
5.37
Volume:
996K
Beta:
1.41

Technical Analysis

SMA50:
3.21
SMA100:
2.57
SMA200:
2.75
52-Wk Change:
195.05%

Stock Predictions

  • Is Protara Therapeutics stock public?
    Yes, Protara Therapeutics is a publicly traded company.
  • What is the Protara Therapeutics stock quote today?
    The Protara Therapeutics stock price is 5.37 USD today.
  • How to buy Protara Therapeutics stock online?
    You can buy Protara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 2.75 2.82 2.89 2.51
Dec-4 2.96 3.54 3.63 2.79
Dec-5 9.45 6.02 10.48 5.95
Dec-6 5.66 5.91 6.47 5.05
Dec-9 6.13 6.67 6.88 5.35
Dec-10 6.30 6.25 6.45 6.10
Dec-11 6.34 6.25 6.35 6.16
Dec-12 6.32 6.25 6.32 6.06
Dec-13 6.38 5.98 6.39 5.63
Dec-16 5.84 5.53 5.98 5.27
Dec-17 5.42 5.62 5.73 5.40
Dec-18 5.40 5.17 5.51 5.00
Dec-19 5.15 5.18 5.32 4.91
Dec-20 5.12 5.37 5.41 5.01

Protara Therapeutics Earnings

Protara Therapeutics Earnings Report: Per Share Protara Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protara Therapeutics Forecast Revenue Growth

Protara Therapeutics Stock Analysis: Historical quarterly revenues per share for Protara Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and a decrease next year of $0.05 per share.

* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.